Ditchcarbon
  • Contact
  1. Organizations
  2. International Stem Cell Corporation
Public Profile
Pharmaceutical Preparation Manufacturing
US
updated 2 months ago

International Stem Cell Corporation Sustainability Profile

Company website

International Stem Cell Corporation (ISCO), headquartered in the United States, is a pioneering entity in the biotechnology industry, specialising in stem cell research and regenerative medicine. Founded in 2007, ISCO has made significant strides in developing innovative therapies and products, particularly in the fields of cell therapy and human therapeutic applications. The company is renowned for its unique human parthenogenetic stem cell technology, which offers a promising alternative to traditional stem cell sources. ISCO's core products include stem cell lines and related research tools, which are designed to advance scientific understanding and therapeutic potential. With a strong market position, ISCO has achieved notable milestones, including collaborations with leading research institutions and advancements in clinical applications, solidifying its reputation as a leader in the stem cell sector.

DitchCarbon Score

How does International Stem Cell Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

26

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

34

Industry Benchmark

International Stem Cell Corporation's score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

43%

Let us know if this data was useful to you

International Stem Cell Corporation's reported carbon emissions

In 2023, International Stem Cell Corporation (ISCC) reported total carbon emissions of approximately 2,585,100 kg CO2e across all scopes. This includes 2,585,100 kg CO2e from Scope 1 emissions, which are direct emissions from owned or controlled sources, and an equal amount from Scope 2 emissions, which are indirect emissions from the generation of purchased electricity, steam, heating, and cooling. Additionally, Scope 3 emissions were also reported at 2,585,100 kg CO2e, with significant contributions from business travel, amounting to 657,630 kg CO2e. Despite the comprehensive emissions reporting, ISCC has not established specific reduction targets or climate pledges, indicating a potential area for future commitment. The absence of cascading data from a parent company suggests that ISCC operates independently in its emissions reporting and climate strategy. Overall, while ISCC has provided detailed emissions data, the lack of defined reduction initiatives highlights an opportunity for the corporation to enhance its climate commitments and align with industry standards for sustainability.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

2023
Scope 1
2,585,100
Scope 2
2,585,100
Scope 3
2,585,100

How Carbon Intensive is International Stem Cell Corporation's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. International Stem Cell Corporation's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is International Stem Cell Corporation's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for International Stem Cell Corporation is in US, which has a low grid carbon intensity relative to other regions.

International Stem Cell Corporation's Scope 3 Categories Breakdown

A significant portion of their carbon footprint comes from suppliers and value chain emissions, with Scope 3 emissions accounting for 33% of total emissions under the GHG Protocol, with "Business Travel" being the primary emissions source at 25% of Scope 3 emissions.

Top Scope 3 Categories

2023
Business Travel
25%

International Stem Cell Corporation's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

International Stem Cell Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare International Stem Cell Corporation's Emissions with Industry Peers

Tocagen Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Athersys, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 18 days ago

Derma Sciences, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated about 1 month ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Amgen

US
•
Pharmaceutical Preparation Manufacturing
Updated 6 days ago

MiMedx Group, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 4 days ago

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251120.2
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy